Qube Research & Technologies Ltd

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1729829 LONDON, X0

Position in FENC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$180,674

-$163,454 QoQ

Shares Held

29,378

-34.3% QoQ

Ownership

0.085%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. FENC ranks #158 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$180,674	29,378	-34.3%	Shares	Sole	2026-05-15
2025-12-31	$344,128	44,692	+103.7%	Shares	Sole	2026-02-17
2024-12-31	$138,648	21,938	-55.0%	Shares	Sole	2025-02-14
2024-09-30	$243,570	48,714	+3.7%	Shares	Sole	2024-11-14
2024-06-30	$287,071	46,984	+428.9%	Shares	Sole	2024-08-14
2024-03-31	$98,790	8,884	-77.9%	Shares	Sole	2024-05-14
2023-03-31	$334,422	40,195	+132.7%	Shares	Sole	2023-05-15
2022-12-31	$165,811	17,272	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.